SMTL ID : 4fk3.1 (2 other biounits)

B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

homo-dimer

Ligands

1 x 325: N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide(Non-covalent)

325.1: 16 residues within 4Å: Chain A: I.32, V.40, A.50, K.52, L.74, L.83, I.96, T.98, Q.99, W.100, C.101, F.152, G.162, D.163, F.164, G.165 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:K.52, A:L.74, A:I.96, A:T.98, A:F.164 Hydrogen bonds: A:T.98, A:Q.99, A:C.101, A:D.163, A:F.164, A:G.165 pi-Cation interactions: A:K.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tsai, J. et al., Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc.Natl.Acad.Sci.USA (2008)

Release Date

2012-08-08

Peptides

Serine/threonine-protein kinase B-raf: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Serine/threonine-protein kinase B-raf

Related Entries With Identical Sequence